Scinovex
articleTop 1% cited

Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

Journal of the American Academy of Dermatology · 2004 · Vol. 51(4) · pp. 534–542
Alice B. GottliebRobert J. EvansShu LiLisa T. DooleyCynthia GuzzoDaniel L. BakerMohan BalaColleen MaranoAlan Menter
Psoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune DisordersMedicineInfliximabPsoriasisPlaceboPsoriasis Area and Severity IndexInternal medicineAdverse effectDermatology Life Quality IndexRandomized controlled trialGastroenterology

MeSH terms

InfliximabAdultAntibodies, MonoclonalDouble-Blind MethodFemaleFlushingHeadacheHumansInfusions, IntravenousMaleMiddle AgedNauseaPsoriasisQuality of LifeSeverity of Illness Index
Citations
581
FWCI
12.61
field-weighted impact
References
45
Percentile
99%
vs. same field & year
Citations per year
Cited by
TNF‐mediated inflammatory disease
The Journal of Pathology · 2007 · 2,005 citations
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Journal of the American Academy of Dermatology · 2019 · 880 citations
Guidelines of care for the management of psoriasis and psoriatic arthritis
Journal of the American Academy of Dermatology · 2008 · 765 citations
Guidelines of care for the management of psoriasis and psoriatic arthritis
Journal of the American Academy of Dermatology · 2008 · 1,202 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.